This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Thomas Spangenberg: Innovator in TLR7/8 Antagonists
Introduction
Thomas Spangenberg is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of TLR7/8 antagonists. His work has implications for various therapeutic applications, showcasing his innovative approach to drug development.
Latest Patents
Thomas Spangenberg holds a patent for "TLR7/8 antagonists and uses thereof." This patent discloses compounds that are useful as TLR7/8 antagonists, along with pharmaceutically acceptable compositions. His innovative work in this area has the potential to advance treatment options for various diseases.
Career Highlights
Spangenberg is associated with Merck Patent GmbH, where he continues to contribute to groundbreaking research and development. His expertise in pharmacology and drug formulation has positioned him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, Thomas has collaborated with talented individuals such as Lukas Shinji Okitsu and Julie DeMartino. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Thomas Spangenberg's contributions to the field of pharmaceuticals, particularly through his patent on TLR7/8 antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.